Значення біохімічних показників для оцінки стану хворих на COVID-19: Огляд літератури

  • Jayshri Sadashiv Jankar Медичний коледж Джавахарлал Неру, Інститут медичних наук Датта Меге, Савангі Меге https://orcid.org/0000-0002-0135-069X
  • Kumud Namdeorao Harley Урядовий медичний коледж
  • Avinash Harishchandra Waghmode Медичний коледж Джавахарлал Неру, Інститут медичних наук Датта Меге, Савангі Меге
DOI: https://doi.org/10.31450/ukrjnd.3(71).2021.09
Ключові слова: біохімічні маркери, COVID-19, лабораторна діагностика, важкий гострий респіраторний синдром (SARS-CoV-2), гостре пошкодження нирок, цитокіни.

Анотація

Резюме. Коронавірусна хвороба (COVID-19) має широкий спектр клінічних ознак від безсимптомного інфікування до важкої пневмонії. Згідно з останніми дослідженнями, пацієнти з COVID-19 мають широкий спектр лабораторних змін, що може бути корисним для виявлення розвитку захворювання та ідентифікації пацієнтів високої групи ризику. У цьому огляді літератури розглядаються потенційні біологічні та імунологічні маркери COVID-19, їх значення у прогресуванні захворювання та вплив на показники функцій печінки, серця, нирок та підшлункової залози.

Завантаження

Дані завантаження ще не доступні.

Посилання

Abuelgasim E, Saw LJ, Shirke M, Zeinah M, Harky A. COVID-19: Unique public health issues facing Black, Asian and minority ethnic communities. Curr Probl Cardiol. 2020;45(8):100621. doi: 10.1016/j.cpcardiol.2020.100621.

Estevão A. Artículo de opinión: COVID-19. Acta Radioló - gica Portuguesa 2020; 32(1): 1–5.

Hamming I, Timens W, Bulthuis ML, Lely AT, Navis G, van Goor H. Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis. J Pathol. 2004;203(2):631-7. doi: 10.1002/path.1570.

Imai Y, Kuba K, Ohto-Nakanishi T, Penninger JM. Angiotensin-converting enzyme 2 (ACE2) in disease pathogenesis. Circ J. 2010;74(3):405-10. doi: 10.1253/circj.cj-10-0045.

 Loeffelholz MJ, Tang YW. Laboratory diagnosis of emerging human coronavirus infections - the state of the art. Emerg Microbes Infect. 2020;9(1):747-756. doi: 10.1080/22221751.2020.1745095.

Yan R, Zhang Y, Li Y, Xia L, Guo Y, Zhou Q. Structural basis for the recognition of SARS-CoV-2 by full-length human ACE2. Science. 2020;367(6485):1444-1448. doi: 10.1126/science.abb2762.

Xu J, Zhao S, Teng T, Abdalla AE, Zhu W, Xie L, Wang Y, Guo X. Systematic Comparison of Two Animal-to-Human Transmitted Human Coronaviruses: SARS-CoV-2 and SARS-CoV. Viruses. 2020;12(2):244. doi: 10.3390/v12020244.

Dong X, Cao YY, Lu XX, Zhang JJ, Du H, Yan YQ, et al. Eleven faces of coronavirus disease 2019. Allergy. 2020;75(7):1699-1709. doi: 10.1111/all.14289.

Kubina R, Dziedzic A. Molecular and Serological Tests for COVID-19 a Comparative Review of SARS-CoV-2 Coronavirus Laboratory and Point-of-Care Diagnostics. Diagnostics (Basel). 2020;10(6):434. doi:10.3390/diagnostics10060434.

Lippi G, Plebani M. The critical role of laboratory medicine during coronavirus disease 2019 (COVID-19) and other viral outbreaks. Clin Chem Lab Med. 2020;58(7):1063-1069. doi: 10.1515/cclm-2020-0240. 

Hernando JEC. Seguimiento de los pacientes con secuelas no respiratorias de la COVID-19. FMC. 2021;28(2):81-89. doi:10.1016/j.fmc.2020.11.004.

Hu B, Huang S, Yin L. The cytokine storm and COVID-19. J Med Virol. 2021;93(1):250-256. doi: 10.1002/jmv.26232.

Liu J, Li S, Liu J, Liang B, Wang X, Wang H, Li W, et al. Longitudinal characteristics of lymphocyte responses and cytokine profiles in the peripheral blood of SARS-CoV-2 infected patients. EBioMedicine. 2020;55:102763. doi: 10.1016/j.ebiom.2020.102763.

Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497-506. doi: 10.1016/S0140-6736(20)30183-5.

Qin C, Zhou L, Hu Z, Zhang S, Yang S, Tao Y, et al. Dysregulation of Immune Response in Patients With Coronavirus 2019 (COVID-19) in Wuhan, China. Clin Infect Dis. 2020;71(15):762-768. doi: 10.1093/cid/ciaa248.

Ahnach M, Zbiri S, Nejjari S, Ousti F, Elkettani C. C-reactive protein as an early predictor of COVID-19 severity. J Med Biochem. 2020;39(4):500-507. doi:10.5937/jomb0-27554.

Tan C, Huang Y, Shi F, Tan K, Ma Q, Chen Y, Jiang X, Li X. C-reactive protein correlates with computed tomographic findings and predicts severe COVID-19 early. J Med Virol. 2020;92(7):856-862. doi: 10.1002/jmv.25871.

Liu W, Tao ZW, Wang L, Yuan ML, Liu K, Zhou L, et al. Analysis of factors associated with disease outcomes in hospitalized patients with 2019 novel coronavirus disease. Chin Med J (Engl). 2020;133(9):1032-1038. doi: 10.1097/CM9.0000000000000775.

Kinoshita A, Onoda H, Imai N, Iwaku A, Oishi M, Tanaka K, et al. The C-reactive protein/albumin ratio, a novel inflammation-based prognostic score, predicts outcomes in patients with hepatocellular carcinoma. Ann Surg Oncol. 2015;22(3):803-10. doi: 10.1245/s10434-014-4048-0.

Fan Z, Chen L, Li J, Cheng X, Yang J, Tian C, Zet al. Clinical Features of COVID-19-Related Liver Functional Abnormality. Clin Gastroenterol Hepatol. 2020;18(7):1561-1566. doi: 10.1016/j.cgh.2020.04.002.

Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, et al. Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. JAMA. 2020;323(11):1061-1069. doi: 10.1001/jama.2020.1585.

Cheng Y, Luo R, Wang K, Zhang M, Wang Z, Dong L, Li J, Yao Y, Ge S, Xu G. Kidney disease is associated with in-hospital death of patients with COVID-19. Kidney Int. 2020;97(5):829-838. doi: 10.1016/j.kint.2020.03.005.

Li Z, Wu M, Yao J, Guo J, Liao X, Song S, et al. Caution on Kidney Dysfunctions of COVID-19 Patients. medRxiv; 2020. doi: 10.1101/2020.02.08.20021212.

Ruan Q, Yang K, Wang W, Jiang L, Song J. Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China. Intensive Care Med. 2020;46(5):846-848. doi: 10.1007/s00134-020-05991-x.

Yuan J, Zou R, Zeng L, Kou S, Lan J, Li X, et al. The correlation between viral clearance and biochemical outcomes of 94 COVID-19 infected discharged patients. Inflamm Res. 2020;69(6):599-606. doi: 10.1007/s00011-020-01342-0.

Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395(10229):1054-1062. doi: 10.1016/S0140-6736(20)30566-3.

Mehta P, McAuley DF, Brown M, Sanchez E, Tattersall RS, Manson JJ; HLH Across Speciality Collaboration, UK. COVID-19: consider cytokine storm syndromes and immunosuppression. Lancet. 2020;395(10229):1033-1034. doi: 10.1016/S0140-6736(20)30628-0.

Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020;395(10223):507-513. doi: 10.1016/S0140-6736(20)30211-7.

Liu Y, Yang Y, Zhang C, Huang F, Wang F, Yuan J, et al. Clinical and biochemical indexes from 2019-nCoV infected patients linked to viral loads and lung injury. Sci China Life Sci. 2020;63(3):364-374. doi: 10.1007/s11427-020-1643-8.

Zhang JJ, Dong X, Cao YY, Yuan YD, Yang YB, Yan YQ, et al. Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China. Allergy. 2020;75(7):1730-1741. doi: 10.1111/all.14238.

Salbach C, Giannitsis E. Kardiale Biomarker und COVID-19-Phänotypen und Interpretation [Cardiac biomarkers and COVID-19 - Phenotypes and Interpretation]. Dtsch Med Wochenschr. 2020;145(11):755-760. [In German]. doi: 10.1055/a-1158-5756.

Perico L, Benigni A, Remuzzi G. Should COVID-19 Concern Nephrologists? Why and to What Extent? The Emerging Impasse of Angiotensin Blockade. Nephron. 2020;144(5):213-221. doi: 10.1159/000507305.

López-Ponce de León JD, Cárdenas-Marín PA, Giraldo- González GC, Herrera-Escandón Á. COVID-19 coronavirus: More than just a lung disease: what it is and what we know about the link with the cardiovascular system. Rev. Colomb. Cardiol. 2020;27(3):142-152.  doi:10.1016/j.rccar.2020.04.006.

Li JW, Han TW, Woodward M, et al. The impact of 2019 novel coronavirus on heart injury: A Systematic review and Meta-analysis. Prog Cardiovasc Dis. 2020;63(4):518-524. doi:10.1016/j.pcad.2020.04.008.

Churchill TW, Bertrand PB, Bernard S, Namasivayam M, Churchill J, Crousillat D, et al. Echocardiographic Features of COVID-19 Illness and Association with Cardiac Biomarkers. J Am Soc Echocardiogr. 2020;33(8):1053-1054. doi: 10.1016/j.echo.2020.05.028.

Deng Q, Hu B, Zhang Y, Wang H, Zhou X, Hu W, Cheng Y, et al. Suspected myocardial injury in patients with COVID-19: Evidence from front-line clinical observation in Wuhan, China. Int J Cardiol. 2020;311:116-121. doi: 10.1016/j.ijcard.2020.03.087.

Cai Q, Huang D, Yu H, et al. COVID-19: Abnormal liver function tests. J Hepatol. 2020;73(3):566-574. doi:10.1016/j.jhep.2020.04.006.

Gong J, Dong H, Xia QS, Huang ZY, Wang DK, Zhao Y, et al. Correlation analysis between disease severity and inflammation-related parameters in patients with COVID-19: a retrospective study. BMC Infect Dis. 2020;20(1):963. doi: 10.1186/s12879-020-05681-5.

Xu Z, Shi L, Wang Y, Zhang J, Huang L, Zhang C, et al. Pathological findings of COVID-19 associated with acute respiratory distress syndrome. Lancet Respir Med. 2020;8(4):420-422. doi: 10.1016/S2213-2600(20)30076-X.

Farcas GA, Poutanen SM, Mazzulli T, Willey BM, Butany J, Asa SL, et al. Fatal severe acute respiratory syndrome is associated with multiorgan involvement by coronavirus. J Infect Dis. 2005;191(2):193-7. doi: 10.1086/426870.

Angel-Korman A, Brosh T, Glick K, Leiba A. Covid-19, the kidney and hypertension. Harefuah. 2020;159(4):231-234. Hebrew.

Diao B, Wang C, Wang R, Feng Z, Zhang J, Yang H, et al. Human kidney is a target for novel severe acute respiratory syndrome coronavirus 2 infection. Nat Commun. 2021;12(1):2506. doi: 10.1038/s41467-021-22781-1.

Zhou H, Zhang Z, Fan H, Li J, Li M, Dong Y, et al. Urinalysis, but not blood biochemistry, detects the earlyrenal-impairment in patients with COVID-19. medRxiv 2020.04.03.20051722. doi: 10.1101/2020.04.03.20051722.

Zhang G, Zhang J, Wang B, Zhu X, Wang Q, Qiu S. Analysis of clinical characteristics and laboratory findings of 95 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a retrospective analysis. Respir Res. 2020;21(1):74. doi: 10.1186/s12931-020-01338-8.

Wang Q, Zhao H, Liu LG, Wang YB, Zhang T, Li MH, et al. Pattern of liver injury in adult patients with COVID-19: a retrospective analysis of 105 patients. Mil Med Res. 2020;7(1):28. doi: 10.1186/s40779-020-00256-6.

Wang F, Wang H, Fan J, Zhang Y, Wang H, Zhao Q. Pancreatic Injury Patterns in Patients With Coronavirus Disease 19 Pneumonia. Gastroenterology. 2020;159(1):367-370. doi: 10.1053/j.gastro.2020.03.055.

Liu F, Long X, Zhang B, Zhang W, Chen X, Zhang Z. ACE2 Expression in Pancreas May Cause Pancreatic Damage After SARS-CoV-2 Infection. Clin Gastroenterol Hepatol. 2020;18(9):2128-2130.e2. doi: 10.1016/j.cgh.2020.04.040.

Hadi A, Werge M, Kristiansen KT, Pedersen UG, Karstensen JG, Novovic S, Gluud LL. Coronavirus Disease-19 (COVID-19) associated with severe acute pancreatitis: Case report on three family members. Pancreatology. 2020 Jun;20(4):665-667. doi: 10.1016/j.pan.2020.04.021.

Cheung KS, Hung IFN, Chan PPY, Lung KC, Tso E, Liu R, et al. Gastrointestinal Manifestations of SARS-CoV-2 Infection and Virus Load in Fecal Samples From a Hong Kong Cohort: Systematic Review and Meta-analysis. Gastroenterology. 2020;159(1):81-95. doi: 10.1053/j.gastro.2020.03.065.

de-Madaria E, Siau K, Cárdenas-Jaén K. Increased Amylase and Lipase in Patients With COVID-19 Pneumonia: Don't Blame the Pancreas Just Yet! Gastroenterology. 2021;160(5):1871. doi: 10.1053/j.gastro.2020.04.044.

Xiang J, Wen J, Yuan X, Xiong S, Zhou XUE, Liu C, et al. Potential biochemical markers to identify severe cases among COVID-19 patients. medRxiv 2020.03.19.20034447. doi:10.1101/2020.03.19.20034447.

Puntmann VO, Carerj ML, Wieters I, Fahim M, Arendt C, Hoffmann J, et al. Outcomes of Cardiovascular Magnetic Resonance Imaging in Patients Recently Recovered From Coronavirus Disease 2019 (COVID-19). JAMA Cardiol. 2020;5(11):1265-1273. doi: 10.1001/jamacardio.2020.3557.

Thompson S, Bohn MK, Mancini N, Loh TP, Wang CB, Grimmler M, et al. IFCC Taskforce on COVID-19. IFCC Interim Guidelines on Biochemical/Hematological Monitoring of COVID-19 Patients. Clin Chem Lab Med. 2020;58(12):2009-2016. doi: 10.1515/cclm-2020-1414.

Li Q, Ding X, Xia G, Chen HG, Chen F, Geng Z, et al. Eosinopenia and elevated C-reactive protein facilitate triage of COVID-19 patients in fever clinic: A retrospective case-control study. EClinicalMedicine. 2020;23:100375. doi: 10.1016/j.eclinm.2020.100375.

Hernández A, Papadakos PJ, Torres A, González DA, Vives M, Ferrando C, Baeza J. Two known therapies could be useful as adjuvant therapy in critical patients infected by COVID-19. Rev Esp Anestesiol Reanim (Engl Ed). 2020;67(5):245-252. [In English, Spanish]. doi: 10.1016/j.redar.2020.03.004.

Wong CK, Lam CW, Wu AK, Ip WK, Lee NL, Chan IH, et al. Plasma inflammatory cytokines and chemokines in severe acute respiratory syndrome. Clin Exp Immunol. 2004;136(1):95-103. doi: 10.1111/j.1365-2249.2004.02415.x.

Henry BM, de Oliveira MHS, Benoit S, Plebani M, Lippi G. Hematologic, biochemical and immune biomarker abnormalities associated with severe illness and mortality in coronavirus disease 2019 (COVID-19): a meta-analysis. Clin Chem Lab Med. 2020 ;58(7):1021-1028. doi: 10.1515/cclm-2020-0369.

Yamamoto N, Bauer G. Apparent difference in fatalities between Central Europe and East Asia due to SARS-COV-2 and COVID-19: Four hypotheses for possible explanation. Med Hypotheses. 2020;144:110160. doi:10.1016/j.mehy.2020.110160.

Messner CB, Demichev V, Wendisch D, Michalick L, White M, Freiwald A, et al. Ultra-High-Throughput Clinical Proteomics Reveals Classifiers of COVID-19 Infection. Cell Syst. 2020;11(1):11-24.e4. doi: 10.1016/j.cels.2020.05.012.

Stankovic B, Kotur N, Gasic V, Klaassen K, Ristivojevic B, Stojiljkovic M, Pavlovic S, Zukic B. Pharmacogenomics landscape of COVID-19 therapy response in Serbian population and comparison with worldwide populations. J Med Biochem 2020; 39(4): 488–99. doi: 10.5937/jomb0-26725.


Переглядів анотації: 674
Завантажень PDF: 15997
Опубліковано
2021-08-13
Як цитувати
Jankar, J. S., Harley, K. N., & Waghmode, A. H. (2021). Значення біохімічних показників для оцінки стану хворих на COVID-19: Огляд літератури. Український Журнал Нефрології та Діалізу, (3(71), 76-87. https://doi.org/10.31450/ukrjnd.3(71).2021.09
Номер
№ 3(71) (2021): Український Журнал Нефрології та Діалізу
Розділ
Школа нефролога